These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18061072)

  • 1. Driving and implantable cardioverter-defibrillators a clearer view.
    Grubb BP
    J Am Coll Cardiol; 2007 Dec; 50(23):2241-2. PubMed ID: 18061072
    [No Abstract]   [Full Text] [Related]  

  • 2. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM; Rosenthal L; Calkins H; Steinberg JS; Ruskin JN; Wang P; Muller JE; Mittleman MA;
    J Am Coll Cardiol; 2007 Dec; 50(23):2233-40. PubMed ID: 18061071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline factors predicting early resumption of driving after life-threatening arrhythmias in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    Hickey K; Curtis AB; Lancaster S; Larsen G; Warwick D; McAnulty J; Mitchell LB
    Am Heart J; 2001 Jul; 142(1):99-104. PubMed ID: 11431664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Driving and ventricular arrhythmia: a historical perspective.
    Falk RH
    J Am Coll Cardiol; 2008 Jul; 52(4):316; author reply 317. PubMed ID: 18634990
    [No Abstract]   [Full Text] [Related]  

  • 5. Anger management may save your life new insights into emotional precipitants of ventricular arrhythmias.
    Rashba EJ
    J Am Coll Cardiol; 2009 Mar; 53(9):779-81. PubMed ID: 19245969
    [No Abstract]   [Full Text] [Related]  

  • 6. Electrical Storms in Patients With Implantable Cardioverter-Defibrillators for Primary Prevention.
    Escande W; Marijon E; Defaye P; Piot O; Leclercq C; Sadoul N; Deharo JC; Empana JP; Boveda S; Klug D
    J Am Coll Cardiol; 2016 Sep; 68(11):1248-1250. PubMed ID: 27609689
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nursing care for automatic implantable defibrillators].
    Pépin A; Samuel B; Kihel A
    Soins; 2006; (702 Suppl):S3-5. PubMed ID: 16493932
    [No Abstract]   [Full Text] [Related]  

  • 8. Monitoring an unstable heart. Implantable cardioverter-defibrillators.
    Mayo Clin Health Lett; 2006 Jun; 24(6):1-3. PubMed ID: 16830395
    [No Abstract]   [Full Text] [Related]  

  • 9. Minimizing inappropriate or "unnecessary" implantable cardioverter-defibrillator shocks: appropriate programming.
    Koneru JN; Swerdlow CD; Wood MA; Ellenbogen KA
    Circ Arrhythm Electrophysiol; 2011 Oct; 4(5):778-90. PubMed ID: 22010117
    [No Abstract]   [Full Text] [Related]  

  • 10. The marriage of true minds: the partner of the ICD patient as a new focus for study.
    Newman D; Crystal E
    Pacing Clin Electrophysiol; 2010 Dec; 33(12):1427-9. PubMed ID: 20946277
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins reduce appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure and combined cardiac resynchronization and implantable cardioverter-defibrillator therapy.
    Desai H; Aronow WS; Tsai FS; Ahn C; Lai HM; Amin H; Gandhi K; Frishman WH; Cohen M; Sorbera C
    J Cardiovasc Pharmacol Ther; 2009 Sep; 14(3):176-9. PubMed ID: 19617418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are implantable cardioverter defibrillators safe for people older than 75?
    Heart Advis; 2009 May; 12(5):8. PubMed ID: 20446360
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anxiety and anxiety management in patients with implanted cardioverter-defibrillators].
    Ladwig KH; Wirsching C; V Hammerstein A; Danner R; Baumert J; Schmitt C
    Dtsch Med Wochenschr; 2004 Oct; 129(43):2311-5. PubMed ID: 15483771
    [No Abstract]   [Full Text] [Related]  

  • 14. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Driving with heart disease.
    Harv Heart Lett; 2001 Dec; 12(4):1-2. PubMed ID: 11751078
    [No Abstract]   [Full Text] [Related]  

  • 16. Inappropriate implantable cardioverter-defibrillator therapy: many causes and many possible solutions.
    Zareba W
    Cardiol J; 2009; 16(5):391-3. PubMed ID: 19753515
    [No Abstract]   [Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator shocks in dying patients: disturbing data from beyond the grave.
    Lampert R
    Circulation; 2014 Jan; 129(4):414-6. PubMed ID: 24243856
    [No Abstract]   [Full Text] [Related]  

  • 18. Is it safe to drive with an automatic implantable cardioverter defibrillator or a history of recurrent symptomatic ventricular arrhythmias?
    Cambre S; Silverman ME
    Heart Dis Stroke; 1993; 2(3):179-81. PubMed ID: 8137022
    [No Abstract]   [Full Text] [Related]  

  • 19. Rates and predictors of appropriate implantable cardioverter-defibrillator therapy delivery: results from the EVADEF cohort study.
    Otmani A; Trinquart L; Marijon E; Lavergne T; Waintraub X; Lepillier A; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Aug; 158(2):230-237.e1. PubMed ID: 19619699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of implant testing of implantable cardioverter defibrillators.
    Swerdlow CD
    J Am Coll Cardiol; 2004 Jul; 44(1):92-4. PubMed ID: 15234414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.